Predisposing factors for advanced liver fibrosis in patients with sickle cell disease
British Journal of Haematology · 2023-09 · 202 (6) · 1192-1198
DOI: 10.1111/bjh.18970 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 12.07.2023. Verfasst von Konstantinos Manganas und 10 weiteren Autor:innen. Beteiligte Einrichtung: Thalassemia and Sickle Cell Unit, Hippokration General Hospital, Athens, Greece. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Liver Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Sickle cell disease (SCD) is one of the most common monogenic disorders worldwide and liver complications are common in this group of patients. Our study aims to highlight the prevalence of chronic liver complications and the main predisposing factors for advanced liver fibrosis in SCD patients. For this purpose, 219 patients from eight Thalassemia and Sickle Cell Units across Greece enrolled in our study and history of liver related disease complications was recorded, as well as a full laboratory and imaging analysis concerning their liver function. 13.6% of the patients had advanced liver fibrosis. The presence of liver fibrosis was significantly correlated with advanced age, male gender, cholelithiasis and higher LDH, γ‐GT, INR, direct and indirect bilirubin levels. These patients had exhibited significantly more episodes of liver crises and acute intrahepatic cholestasis. No correlation was observed with right heart failure or previous viral hepatitis. Patients with advanced liver fibrosis were receiving a more intensive transfusion therapy for a longer period of time and had higher Liver Iron Concentration levels. Our study shows that liver complications and cirrhosis is a significant cause of morbidity in patients with SCD and it is primarily associated with intravascular hemolysis and vaso‐occlusive phenomena and secondarily with iron overload.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Thalassemia and Sickle Cell Unit, Hippokration General Hospital, Athens, Greece.
- Thalassemia & Hemoglobinopathies Unit, Hematology Division, Department of Internal Medicine, University of Patras Medical School, University Hospital, Patras, Greece.
- Thalassemia and Sickle Cell Unit, General Hospital of Athens "Evaggelismos", Athens, Greece.
- Thalassemia and Sickle Cell Unit, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
- Thalassemia and Sickle Cell Unit, "Venizelion" General Hospital, Heraklion, Greece.
- Thalassemia and Sickle Cell Unit, General Hospital of Larissa, Larissa, Greece.
ORCID-Profile: Konstantinos Manganas, Antonios Kattamis
Zitieren
APA
Manganas, K., Delicou, S., Xydaki, A., Kourakli, A., Evliati, L., Vlachaki, E., Klironomos, E., Diamantidis, M., Lafiatis, I., Kattamis, A., & Koskinas, J. (2023). Predisposing factors for advanced liver fibrosis in patients with sickle cell disease. British Journal of Haematology, 202(6), 1192-1198. https://doi.org/10.1111/bjh.18970
Vancouver
Manganas K, Delicou S, Xydaki A, Kourakli A, Evliati L, Vlachaki E, et al. Predisposing factors for advanced liver fibrosis in patients with sickle cell disease. British Journal of Haematology. 2023;202(6):1192-1198. doi:10.1111/bjh.18970
BibTeX
@article{Manganas2023,
author = {Manganas, Konstantinos and Delicou, Sophia and Xydaki, Aikaterini and Kourakli, Alexandra and Evliati, Loukia and Vlachaki, Efthymia and Klironomos, Evangelos and Diamantidis, Michail and Lafiatis, Ioannis and Kattamis, Antonios and Koskinas, John},
title = {Predisposing factors for advanced liver fibrosis in patients with sickle cell disease},
journal = {British Journal of Haematology},
year = {2023},
volume = {202},
number = {6},
pages = {1192--1198},
doi = {10.1111/bjh.18970}
}
EUVIMED